Skip to main content

AD: Shocked! The peak value of plasma Aβ42/Aβ40 began to decline 41 years before the deposition of brain Aβ!

 AD: Shocked! The peak value of plasma Aβ42/Aβ40 began to decline 41 years before the deposition of brain Aβ! Alzheimer's diseases: New discovery on plasma Aβ42/Aβ40.  AD: Shocked! The peak value of plasma Aβ42/Aβ40 began to decline 41 years before the deposition of brain Aβ! Amyloid β (Aβ) plaque deposition and phosphorylated tau (p-tau) protein tangles are two important pathological features of Alzheimer's disease (AD), and there are many kinds of AD biomarkers derived around them, Knowledge of the longitudinal trajectories of key markers could not only help improve the selection and monitoring of participants in clinical trials, but also help identify those at high risk for neurodegenerative changes and cognitive impairment.   Although research on AD biomarkers has increased substantially in recent years, research on longitudinal changes in biomarkers is relatively limited. Studies have shown that the levels of plasma Aβ 42 /Aβ 40 , p-tau181 and glial fibrillary acidic...

Inactivated vaccines vs. mRNA vaccines: Advantages and disadvantages

Inactivated vaccines vs. mRNA vaccines: Advantages and disadvantages



Inactivated vaccine refers to the cultivation of viruses or bacteria, and then inactivation of them with heat or chemical agents (usually formalin). Inactivated vaccines can be composed of whole viruses or bacteria, and can also be composed of their split fragments to form split vaccines.





The mRNA vaccine is a new type of vaccine that produces antigens by introducing mRNA into somatic cells, and then achieves the immune effect.


The main advantages of inactivated vaccines: 1. Easy to store; 2. No risk of contamination; 3. Insensitive to the neutralization of maternal antibodies; 4. Easy to make combined vaccines or multivalent vaccines.


The main disadvantages of inactivated vaccines are: 1. The immunity period is short and requires multiple vaccination; 2. The production speed is slow and the production cost is high; 3. It mainly stimulates humoral immunity and fails to produce better mucosal immunity; 4. Inoculation dose Great; 5. Unable to deal with virus mutation.


Compared with traditional vaccines, mRNA vaccines have many advantages in theory: 1. Safe; 2. Effective; 3. Fast production speed and low production cost; 4. Can deal with virus mutations.


Disadvantages of mRNA vaccines: 1. The storage and transportation conditions are harsh, requiring cold chain transportation; 2. The technology is new and lacks historical accumulation.


The characteristic of the mRNA vaccine is that the production speed is very fast. The United States can produce more than one billion vaccines a year, and the output of three months can realize the universal injection of the United States. The output of one year can meet the needs of the people in dozens of countries. On the contrary, the production speed of inactivated vaccines is slow, and it is necessary to cultivate and multiply the eggs implanted with the virus for many days. The production cycle is long and the speed is slow. Sinopharm’s inactivated vaccines can produce about 20 million doses a month and more than 200 million doses a year. It will take seven years to achieve universal injection in China.


mRNA vaccines can cope with virus mutations to a high degree, but inactivated vaccines cannot. Once the virus has mutated, the inactivated vaccines will be scrapped. New inactivated vaccines need to be re-developed, and a longer development and production cycle is required .


Compared with traditional vaccines, mRNA vaccines have low cost, high production efficiency, and can induce cellular immunity and humoral immunity at the same time. Because mRNA vaccines can be produced cell-free and do not need to introduce toxic chemicals during production, and the production speed is fast, the chance of contamination by microorganisms is relatively low, and the safety of RNA vaccines is relatively high. On the other hand, there is relatively little knowledge about the long-term side effects of mRNA vaccines, and mRNA vaccines also have the risk of autoimmunity.

Popular posts from this blog

After 70 years of age, language ability declines significantly, and more play and activity can delay it!

After 70 years of age, language ability declines significantly, and more play and activity can delay it!  70~74 years old is a turning point in the decline of language ability Playing more and more active can delay the decline of speech function Liu Chuqun, Professor of Jiangxi Normal University Decreased language fluency is an important speech performance of the elderly.  Studies have found that the age of 70 to 74 is an important turning point for the decline of verbal fluency, but a positive attitude and a healthy lifestyle can delay the decline of the elderly’s verbal fluency to a certain extent. After 70 years of age, language ability declines significantly Most of the elderly, especially the elderly, have these kinds of expressions: words that have no real meaning are repeated back and forth, lack of information to express, the words are inconsistent with what they think and form a verbal error, and the words cannot be remembered by the mouth (tip of tongue phenomenon), ...

European Medicines Agency investigates whether Johnson & Johnson COVID-19 vaccine is associated with thrombosis

European Medicines Agency investigates whether Johnson & Johnson COVID-19 vaccine is associated with thrombosis European Medicines Agency investigates whether Johnson & Johnson COVID-19 vaccine is associated with thrombosis. The European Medicines Agency said on the 9th that it is investigating whether the new crown vaccine developed by Johnson & Johnson Pharmaceuticals Co., Ltd. is associated with thrombosis. In the United States, four Johnson & Johnson vaccinators developed blood clots. This regulatory agency continues to investigate whether there is a causal link between the new crown vaccine developed by AstraZeneca Pharmaceuticals in the United Kingdom and the presence of blood clots in the vaccinators, and it has also found that some vaccinators have other diseases. Thrombosis associated with Johnson & Johnson vaccine? The European Medicines Agency said in a report on the 9th that four Johnson & Johnson vaccine vaccinators in the United States had severe t...

Medical news update on March 27 2022

  Medical news update on March 27 2022 Drugs News GlaxoSmithKline anti-HIV injectable drug gets the latest FDA approval!  7 mins ago GlaxoSmithKline anti-HIV injectable drug gets the latest FDA approval!   GlaxoSmithKline's anti-HIV injectable drug gets the latest FDA approval! Direct... Cancers Immunotherapy News Tumors How about patients now after CAR-T cell infusion ten years ago?  8 mins ago How about patients now after CAR-T cell infusion ten years ago?   How about patients now after CAR-T cell infusion... Cancers News Stem Cells Cell Stem Cell: Do Human Stem Cells Contain Oncogenic Mutations?  10 mins ago Cell Stem Cell: Do Human Stem Cells Contain Oncogenic Mutations?   Cell Stem Cell: Do Human Stem Cells Contain Oncogenic... COVID-19 News Simultaneous infection with COVID-19 and influenza increases the risk of severe illness and death  11 mins ago Simultaneous infection with COVID-19 and influenza increases the risk of severe illness and d...